CAR-T Therapy has shown an unprecedented success in the treatment of Hematological Tumors. In order to develop an Universal CAR-T based in own technology, Canvax Biotech has executed the project «Dymorphic and Universal CAR-T for Cancer Immunotherapy, Infectious and Autoimmune Diseases». This project has been co-funded by CDTI and Fondo Europeo de Desarrollo Regional (FEDER) […]
Learn More